Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

IL-23-producing IL-10Rα-deficient gut macrophages elicit an IL-22-driven proinflammatory epithelial cell response.

Bernshtein B, Curato C, Ioannou M, Thaiss CA, Gross-Vered M, Kolesnikov M, Wang Q, David E, Chappell-Maor L, Harmelin A, Elinav E, Thakker P, Papayannopoulos V, Jung S.

Sci Immunol. 2019 Jun 14;4(36). pii: eaau6571. doi: 10.1126/sciimmunol.aau6571.

PMID:
31201258
2.

The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs.

Virtue AT, McCright SJ, Wright JM, Jimenez MT, Mowel WK, Kotzin JJ, Joannas L, Basavappa MG, Spencer SP, Clark ML, Eisennagel SH, Williams A, Levy M, Manne S, Henrickson SE, Wherry EJ, Thaiss CA, Elinav E, Henao-Mejia J.

Sci Transl Med. 2019 Jun 12;11(496). pii: eaav1892. doi: 10.1126/scitranslmed.aav1892.

PMID:
31189717
3.

The cancer microbiome.

Elinav E, Garrett WS, Trinchieri G, Wargo J.

Nat Rev Cancer. 2019 Jun 11. doi: 10.1038/s41568-019-0155-3. [Epub ahead of print] Review.

PMID:
31186547
4.

The pros, cons, and many unknowns of probiotics.

Suez J, Zmora N, Segal E, Elinav E.

Nat Med. 2019 May;25(5):716-729. doi: 10.1038/s41591-019-0439-x. Epub 2019 May 6. Review.

PMID:
31061539
5.

Probiotics in the next-generation sequencing era.

Suez J, Zmora N, Elinav E.

Gut Microbes. 2019 Apr 5:1-17. doi: 10.1080/19490976.2019.1586039. [Epub ahead of print]

PMID:
30951391
6.

Microbiome diurnal rhythmicity and its impact on host physiology and disease risk.

Nobs SP, Tuganbaev T, Elinav E.

EMBO Rep. 2019 Apr;20(4). pii: e47129. doi: 10.15252/embr.201847129. Epub 2019 Mar 15. Review.

PMID:
30877136
7.

No guts, no research glory.

Elinav E.

Nat Med. 2019 Feb;25(2):196. doi: 10.1038/s41591-019-0342-5. No abstract available.

PMID:
30728539
8.

Transforming medicine with the microbiome.

Zmora N, Soffer E, Elinav E.

Sci Transl Med. 2019 Jan 30;11(477). pii: eaaw1815. doi: 10.1126/scitranslmed.aaw1815. Review.

PMID:
30700573
9.

Mutual interplay between IL-17-producing γδT cells and microbiota orchestrates oral mucosal homeostasis.

Wilharm A, Tabib Y, Nassar M, Reinhardt A, Mizraji G, Sandrock I, Heyman O, Barros-Martins J, Aizenbud Y, Khalaileh A, Eli-Berchoer L, Elinav E, Wilensky A, Förster R, Bercovier H, Prinz I, Hovav AH.

Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2652-2661. doi: 10.1073/pnas.1818812116. Epub 2019 Jan 28.

PMID:
30692259
10.

Correction to: Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells.

Chao K, Zhang S, Qiu Y, Chen X, Zhang X, Cai C, Peng Y, Mao R, Pevsner-Fischer M, Ben-Horin S, Elinav E, Zeng Z, Chen B, He Y, Xiang AP, Chen M.

Stem Cell Res Ther. 2019 Jan 21;10(1):33. doi: 10.1186/s13287-019-1132-1.

11.

The role of the microbiome in NAFLD and NASH.

Kolodziejczyk AA, Zheng D, Shibolet O, Elinav E.

EMBO Mol Med. 2019 Feb;11(2). pii: e9302. doi: 10.15252/emmm.201809302. Review.

12.

Translating microbiome futures.

Taroncher-Oldenburg G, Jones S, Blaser M, Bonneau R, Christey P, Clemente JC, Elinav E, Ghedin E, Huttenhower C, Kelly D, Kyle D, Littman D, Maiti A, Maue A, Olle B, Segal L, van Hylckama Vlieg JET, Wang J.

Nat Biotechnol. 2018 Nov 9;36(11):1037-1042. doi: 10.1038/nbt.4287. No abstract available.

PMID:
30412201
13.

The Citrobacter rodentium type III secretion system effector EspO affects mucosal damage repair and antimicrobial responses.

Berger CN, Crepin VF, Roumeliotis TI, Wright JC, Serafini N, Pevsner-Fischer M, Yu L, Elinav E, Di Santo JP, Choudhary JS, Frankel G.

PLoS Pathog. 2018 Oct 26;14(10):e1007406. doi: 10.1371/journal.ppat.1007406. eCollection 2018 Oct.

14.

You are what you eat: diet, health and the gut microbiota.

Zmora N, Suez J, Elinav E.

Nat Rev Gastroenterol Hepatol. 2019 Jan;16(1):35-56. doi: 10.1038/s41575-018-0061-2. Review.

PMID:
30262901
15.

Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT.

Suez J, Zmora N, Zilberman-Schapira G, Mor U, Dori-Bachash M, Bashiardes S, Zur M, Regev-Lehavi D, Ben-Zeev Brik R, Federici S, Horn M, Cohen Y, Moor AE, Zeevi D, Korem T, Kotler E, Harmelin A, Itzkovitz S, Maharshak N, Shibolet O, Pevsner-Fischer M, Shapiro H, Sharon I, Halpern Z, Segal E, Elinav E.

Cell. 2018 Sep 6;174(6):1406-1423.e16. doi: 10.1016/j.cell.2018.08.047.

PMID:
30193113
16.

Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features.

Zmora N, Zilberman-Schapira G, Suez J, Mor U, Dori-Bachash M, Bashiardes S, Kotler E, Zur M, Regev-Lehavi D, Brik RB, Federici S, Cohen Y, Linevsky R, Rothschild D, Moor AE, Ben-Moshe S, Harmelin A, Itzkovitz S, Maharshak N, Shibolet O, Shapiro H, Pevsner-Fischer M, Sharon I, Halpern Z, Segal E, Elinav E.

Cell. 2018 Sep 6;174(6):1388-1405.e21. doi: 10.1016/j.cell.2018.08.041.

PMID:
30193112
17.

NLRP6 and Dysbiosis: Avoiding the Luring Attraction of Over-Simplification.

Elinav E, Henao-Mejia J, Strowig T, Flavell R.

Immunity. 2018 Apr 17;48(4):603-604. doi: 10.1016/j.immuni.2018.04.002. No abstract available.

18.

Loss of MicroRNA-21 Influences the Gut Microbiota, Causing Reduced Susceptibility in a Murine Model of Colitis.

Johnston DGW, Williams MA, Thaiss CA, Cabrera-Rubio R, Raverdeau M, McEntee C, Cotter PD, Elinav E, O'Neill LAJ, Corr SC.

J Crohns Colitis. 2018 Jun 28;12(7):835-848. doi: 10.1093/ecco-jcc/jjy038.

PMID:
29608690
19.

Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection.

Thaiss CA, Levy M, Grosheva I, Zheng D, Soffer E, Blacher E, Braverman S, Tengeler AC, Barak O, Elazar M, Ben-Zeev R, Lehavi-Regev D, Katz MN, Pevsner-Fischer M, Gertler A, Halpern Z, Harmelin A, Aamar S, Serradas P, Grosfeld A, Shapiro H, Geiger B, Elinav E.

Science. 2018 Mar 23;359(6382):1376-1383. doi: 10.1126/science.aar3318. Epub 2018 Mar 8.

PMID:
29519916
20.

Environment dominates over host genetics in shaping human gut microbiota.

Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, Costea PI, Godneva A, Kalka IN, Bar N, Shilo S, Lador D, Vila AV, Zmora N, Pevsner-Fischer M, Israeli D, Kosower N, Malka G, Wolf BC, Avnit-Sagi T, Lotan-Pompan M, Weinberger A, Halpern Z, Carmi S, Fu J, Wijmenga C, Zhernakova A, Elinav E, Segal E.

Nature. 2018 Mar 8;555(7695):210-215. doi: 10.1038/nature25973. Epub 2018 Feb 28.

PMID:
29489753
21.

Sieving through gut models of colonization resistance.

Mullineaux-Sanders C, Suez J, Elinav E, Frankel G.

Nat Microbiol. 2018 Feb;3(2):132-140. doi: 10.1038/s41564-017-0095-1. Epub 2018 Jan 22. Review.

PMID:
29358683
22.

The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiota.

Alteber Z, Sharbi-Yunger A, Pevsner-Fischer M, Blat D, Roitman L, Tzehoval E, Elinav E, Eisenbach L.

Immunol Cell Biol. 2018 Mar;96(3):284-297. doi: 10.1111/imcb.12000. Epub 2018 Jan 22.

PMID:
29356071
23.

Sequential BMP7/TGF-β1 signaling and microbiota instruct mucosal Langerhans cell differentiation.

Capucha T, Koren N, Nassar M, Heyman O, Nir T, Levy M, Zilberman-Schapira G, Zelentova K, Eli-Berchoer L, Zenke M, Hieronymus T, Wilensky A, Bercovier H, Elinav E, Clausen BE, Hovav AH.

J Exp Med. 2018 Feb 5;215(2):481-500. doi: 10.1084/jem.20171508. Epub 2018 Jan 17.

24.

Bile acids in glucose metabolism in health and disease.

Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E.

J Exp Med. 2018 Feb 5;215(2):383-396. doi: 10.1084/jem.20171965. Epub 2018 Jan 16. Review.

25.

Citrobacter rodentium Relies on Commensals for Colonization of the Colonic Mucosa.

Mullineaux-Sanders C, Collins JW, Ruano-Gallego D, Levy M, Pevsner-Fischer M, Glegola-Madejska IT, Sågfors AM, Wong JLC, Elinav E, Crepin VF, Frankel G.

Cell Rep. 2017 Dec 19;21(12):3381-3389. doi: 10.1016/j.celrep.2017.11.086.

26.

Our Gut Microbiome: The Evolving Inner Self.

Kundu P, Blacher E, Elinav E, Pettersson S.

Cell. 2017 Dec 14;171(7):1481-1493. doi: 10.1016/j.cell.2017.11.024. Review.

27.

Towards utilization of the human genome and microbiome for personalized nutrition.

Bashiardes S, Godneva A, Elinav E, Segal E.

Curr Opin Biotechnol. 2018 Jun;51:57-63. doi: 10.1016/j.copbio.2017.11.013. Epub 2017 Dec 7. Review.

PMID:
29223004
28.

Microbiome at the Frontier of Personalized Medicine.

Kashyap PC, Chia N, Nelson H, Segal E, Elinav E.

Mayo Clin Proc. 2017 Dec;92(12):1855-1864. doi: 10.1016/j.mayocp.2017.10.004. Review.

29.

NFIL-trating the Host Circadian Rhythm-Microbes Fine-Tune the Epithelial Clock.

Thaiss CA, Nobs SP, Elinav E.

Cell Metab. 2017 Nov 7;26(5):699-700. doi: 10.1016/j.cmet.2017.10.014.

30.

Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation.

Atarashi K, Suda W, Luo C, Kawaguchi T, Motoo I, Narushima S, Kiguchi Y, Yasuma K, Watanabe E, Tanoue T, Thaiss CA, Sato M, Toyooka K, Said HS, Yamagami H, Rice SA, Gevers D, Johnson RC, Segre JA, Chen K, Kolls JK, Elinav E, Morita H, Xavier RJ, Hattori M, Honda K.

Science. 2017 Oct 20;358(6361):359-365. doi: 10.1126/science.aan4526.

31.

Citrobacter rodentium Subverts ATP Flux and Cholesterol Homeostasis in Intestinal Epithelial Cells In Vivo.

Berger CN, Crepin VF, Roumeliotis TI, Wright JC, Carson D, Pevsner-Fischer M, Furniss RCD, Dougan G, Dori-Bachash M, Yu L, Clements A, Collins JW, Elinav E, Larrouy-Maumus GJ, Choudhary JS, Frankel G.

Cell Metab. 2017 Nov 7;26(5):738-752.e6. doi: 10.1016/j.cmet.2017.09.003. Epub 2017 Oct 5.

32.

Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial.

Sherf-Dagan S, Zelber-Sagi S, Zilberman-Schapira G, Webb M, Buch A, Keidar A, Raziel A, Sakran N, Goitein D, Goldenberg N, Mahdi JA, Pevsner-Fischer M, Zmora N, Dori-Bachash M, Segal E, Elinav E, Shibolet O.

Int J Obes (Lond). 2018 Feb;42(2):147-155. doi: 10.1038/ijo.2017.210. Epub 2017 Aug 30.

PMID:
28852205
33.

Circadian Coordination of Antimicrobial Responses.

Tognini P, Thaiss CA, Elinav E, Sassone-Corsi P.

Cell Host Microbe. 2017 Aug 9;22(2):185-192. doi: 10.1016/j.chom.2017.07.007. Review.

34.

The remedy within: will the microbiome fulfill its therapeutic promise?

Thaiss CA, Elinav E.

J Mol Med (Berl). 2017 Oct;95(10):1021-1027. doi: 10.1007/s00109-017-1563-z. Epub 2017 Jun 27. Review.

PMID:
28656322
35.

Post-dieting weight gain: the role of persistent microbiome changes.

Thaiss CA, Shapiro H, Elinav E.

Future Microbiol. 2017 Jun;12:555-559. doi: 10.2217/fmb-2017-0045. Epub 2017 Jun 12. No abstract available.

PMID:
28604101
36.

Bread Affects Clinical Parameters and Induces Gut Microbiome-Associated Personal Glycemic Responses.

Korem T, Zeevi D, Zmora N, Weissbrod O, Bar N, Lotan-Pompan M, Avnit-Sagi T, Kosower N, Malka G, Rein M, Suez J, Goldberg BZ, Weinberger A, Levy AA, Elinav E, Segal E.

Cell Metab. 2017 Jun 6;25(6):1243-1253.e5. doi: 10.1016/j.cmet.2017.05.002.

37.

The path towards microbiome-based metabolite treatment.

Suez J, Elinav E.

Nat Microbiol. 2017 May 25;2:17075. doi: 10.1038/nmicrobiol.2017.75.

PMID:
28540921
38.

The microbiome in anti-cancer therapy.

Bashiardes S, Tuganbaev T, Federici S, Elinav E.

Semin Immunol. 2017 Aug;32:74-81. doi: 10.1016/j.smim.2017.04.001. Epub 2017 Apr 18. Review.

PMID:
28431920
39.

Inflammasomes and intestinal inflammation.

Zmora N, Levy M, Pevsner-Fishcer M, Elinav E.

Mucosal Immunol. 2017 Jul;10(4):865-883. doi: 10.1038/mi.2017.19. Epub 2017 Apr 12. Review.

PMID:
28401932
40.

The Role of the Immune System in Metabolic Health and Disease.

Zmora N, Bashiardes S, Levy M, Elinav E.

Cell Metab. 2017 Mar 7;25(3):506-521. doi: 10.1016/j.cmet.2017.02.006. Review.

41.

Dysbiosis and the immune system.

Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E.

Nat Rev Immunol. 2017 Apr;17(4):219-232. doi: 10.1038/nri.2017.7. Epub 2017 Mar 6. Review.

PMID:
28260787
42.

NLRP6: A Multifaceted Innate Immune Sensor.

Levy M, Shapiro H, Thaiss CA, Elinav E.

Trends Immunol. 2017 Apr;38(4):248-260. doi: 10.1016/j.it.2017.01.001. Epub 2017 Feb 15. Review.

PMID:
28214100
43.

Microbiome-Modulated Metabolites at the Interface of Host Immunity.

Blacher E, Levy M, Tatirovsky E, Elinav E.

J Immunol. 2017 Jan 15;198(2):572-580. doi: 10.4049/jimmunol.1601247. Review.

44.

GAS6 is a key homeostatic immunological regulator of host-commensal interactions in the oral mucosa.

Nassar M, Tabib Y, Capucha T, Mizraji G, Nir T, Pevsner-Fischer M, Zilberman-Schapira G, Heyman O, Nussbaum G, Bercovier H, Wilensky A, Elinav E, Burstyn-Cohen T, Hovav AH.

Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):E337-E346. doi: 10.1073/pnas.1614926114. Epub 2017 Jan 3.

45.

Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations.

Thaiss CA, Levy M, Korem T, Dohnalová L, Shapiro H, Jaitin DA, David E, Winter DR, Gury-BenAri M, Tatirovsky E, Tuganbaev T, Federici S, Zmora N, Zeevi D, Dori-Bachash M, Pevsner-Fischer M, Kartvelishvily E, Brandis A, Harmelin A, Shibolet O, Halpern Z, Honda K, Amit I, Segal E, Elinav E.

Cell. 2016 Dec 1;167(6):1495-1510.e12. doi: 10.1016/j.cell.2016.11.003.

46.

Persistent microbiome alterations modulate the rate of post-dieting weight regain.

Thaiss CA, Itav S, Rothschild D, Meijer MT, Levy M, Moresi C, Dohnalová L, Braverman S, Rozin S, Malitsky S, Dori-Bachash M, Kuperman Y, Biton I, Gertler A, Harmelin A, Shapiro H, Halpern Z, Aharoni A, Segal E, Elinav E.

Nature. 2016 Dec 22;540(7634):544-551. doi: 10.1038/nature20796. Epub 2016 Nov 24.

PMID:
27906159
47.

Microbiome, metabolites and host immunity.

Levy M, Blacher E, Elinav E.

Curr Opin Microbiol. 2017 Feb;35:8-15. doi: 10.1016/j.mib.2016.10.003. Epub 2016 Nov 22. Review.

PMID:
27883933
48.

The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury.

Hu B, Jin C, Li HB, Tong J, Ouyang X, Cetinbas NM, Zhu S, Strowig T, Lam FC, Zhao C, Henao-Mejia J, Yilmaz O, Fitzgerald KA, Eisenbarth SC, Elinav E, Flavell RA.

Science. 2016 Nov 11;354(6313):765-768.

49.

The gut microbiome and hypertension.

Pevsner-Fischer M, Blacher E, Tatirovsky E, Ben-Dov IZ, Elinav E.

Curr Opin Nephrol Hypertens. 2017 Jan;26(1):1-8. Review.

PMID:
27798455
50.

Personalized microbiome-based approaches to metabolic syndrome management and prevention.

Shapiro H, Suez J, Elinav E.

J Diabetes. 2017 Mar;9(3):226-236. doi: 10.1111/1753-0407.12501. Review.

PMID:
27787945

Supplemental Content

Loading ...
Support Center